Medical economics

Start talking about mRNA vaccine access now, say experts

While researchers are still in the early stages of development for new mRNA vaccines, global health leaders focused on the world's most neglected infectious diseases say that conversations about access should begin now.

Vaccination

Do you need another COVID-19 booster?

As the U.S. enters its third year of the pandemic, COVID-19 cases are at an all-time high thanks to the highly transmissible omicron variant.

Vaccination

France's Sanofi halts work on mRNA Covid vaccine

French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.

Diseases, Conditions, Syndromes

With pandemic worsening in US, surgeon general worried

The U.S. surgeon general said Sunday that he's concerned about what lies ahead with cases of COVID-19 increasing in every state, millions still unvaccinated and a highly contagious virus variant spreading rapidly.

page 4 from 8